Health
CoVIg-19 Plasma Alliance announces outcomes of NIH-funded Phase 3 ITAC clinical trial – News-Medical.Net
The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded…
The CoVIg-19 Plasma Alliance today announced that the Phase 3 Inpatient Treatment with Anti-Coronavirus Immunoglobulin (ITAC) clinical trial sponsored and funded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), did not meet its endpoints. No serious safety signals were raised in the trial.
The study aimed to determine whether an investigational anti-coronavirus hyperimmune intravenous immunoglobulin (H-Ig) medicine (referred to…
-
Noosa News22 hours agoChild sex offenders to be known in Queensland public registry
-
General22 hours agoThousands flood cities demanding action on Palestine
-
General21 hours agoNRLW Sunday: Brisbane Broncos hammer Newcastle Knights, Cronulla Sharks move to third on ladder
-
General13 hours agoFirst home buyers score early access to deposit scheme